Lumida
/NMRA
⌘K
Neumora Therapeutics Inc

Neumora Therapeutics Inc

NMRA
$1.61USD+0.63%+0.01 today

MARKET CAP

298.3M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$1
$4

AI Summary

Stalk
Buy NowMedium

NMRA is basing in an early Stage 1 consolidation with price forming higher highs and higher lows above the short-term EMAs, signaling stabilization and a foundation for a trend reversal. Short-term EMAs (9/21) have shifted to support and price is holding above them, offering a favorable pullback entry. The active Higher Highs & Higher Lows pattern indicates demand dominance and a bullish medium-term stance, despite the long-term downtrend persisting.

  • Up to six clinical data readouts next 18 months (NMRA-511, NMRA-215)
  • $217.6M cash supports operations into Q3 2027
  • Navacaprant program discontinued after Coastal 1 failed to show statistical benefit
Full analysis →
Insider Trades19 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 17, 2026SellNMRAMichael Lee Milligan1,436$3.56$298.3M-55.89%+93.93%$5.1K-6.39%10b5-1Buy Now
Feb 17, 2026SellNMRAJoshua PintoPresident5,967$3.54$298.3M-55.89%+93.93%$21.1K-9.36%Buy Now
Feb 17, 2026SellNMRADaljit Singh Aurora6,165$3.56$298.3M-55.89%+93.93%$21.9K-6.93%Buy Now
Feb 17, 2026SellNMRAPaul L Berns9,819$3.51$298.3M-55.89%+93.93%$34.5K-0.13%Buy Now
Nov 11, 2025SellNMRADaljit Singh Aurora114,703$2.68$298.3M-55.89%+93.93%$307.0K-100.00%10b5-1Buy Now
May 21, 2025SellNMRAJoshua PintoPresident26,404$0.75$298.3M-55.89%+93.93%$19.9K+0.00%Buy Now
Feb 18, 2025SellNMRAMichael Lee Milligan1,978$1.69$298.3M-55.89%+93.93%$3.4K-8.09%10b5-1Buy Now
Feb 18, 2025SellNMRARobert A. LenzHead of R&D5,614$1.67$298.3M-55.89%+93.93%$9.4K-1.78%10b5-1Buy Now
Feb 18, 2025SellNMRAJoshua PintoPresident8,048$1.67$298.3M-55.89%+93.93%$13.5K-9.47%10b5-1Buy Now
Feb 18, 2025SellNMRADaljit Singh AuroraChief Strategy Officer8,565$1.68$298.3M-55.89%+93.93%$14.3K-8.78%10b5-1Buy Now
Feb 18, 2025SellNMRAPaul L Berns13,871$1.69$298.3M-55.89%+93.93%$23.5K-0.19%10b5-1Buy Now
Oct 9, 2024SellNMRARobert A. LenzHead of R&D13,823$15.06$298.3M-55.89%+93.93%$208.1K-2.12%10b5-1Buy Now
Sep 17, 2024SellNMRARobert A. LenzHead of R&D41,464$11.89$298.3M-55.89%+93.93%$492.8K-5.85%10b5-1Buy Now
Sep 12, 2024SellNMRARobert A. LenzHead of R&D32,948$11.43$298.3M-55.89%+93.93%$376.7K-8.18%10b5-1Buy Now
Aug 27, 2024SellNMRAJoshua PintoChief Financial Officer15,693$11.39$298.3M-55.89%+93.93%$178.8K-10.15%10b5-1Buy Now
Aug 22, 2024SellNMRAJoshua PintoChief Financial Officer84,307$11.67$298.3M-55.89%+93.93%$984.1K-13.26%10b5-1Buy Now
Apr 22, 2024SellNMRADaljit Singh AuroraChief Strategy Officer114,703$10.41$298.3M-55.89%+93.93%$1.2M-54.05%Buy Now
Apr 17, 2024SellNMRAJoshua PintoChief Financial Officer238,965$10.47$298.3M-55.89%+93.93%$2.5M-50.00%Buy Now
Sep 19, 2023BuyNMRAHenry O GosebruchPresident & CEO15,000$12.62$298.3M-55.89%+93.93%$189.4KBuy Now